Stock 0D13 VISIOMED GROUP
Add to a list
To use this feature you must be a member
Log inSign up

Visiomed Group Share Price London S.E.

Equities

0D13

FR0013481835

Medical Equipment, Supplies & Distribution

Delayed London S.E.
Other stock markets
 09:05:38 22/05/2018 pm IST 		5-day change 1st Jan Change
0.417 EUR -0.48% Intraday chart for Visiomed Group -.--% -.--%
26/03 Visiomed: share price rises on 'record' 2023 results CF
13/02 Visiomed: 38% increase in annual sales CF

Financials

Sales 2021 7.18M 7.69M 642M Sales 2022 14.44M 15.48M 1.29B Capitalization 98.55M 106M 8.81B
Net income 2021 -4M -4.29M -358M Net income 2022 -5M -5.36M -447M EV / Sales 2021 1.38 x
Net cash position 2021 1.62M 1.73M 144M Net Debt 2022 3.26M 3.49M 291M EV / Sales 2022 7.05 x
P/E ratio 2021
-1.33 x
P/E ratio 2022
-22.7 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 99.97%
More Fundamentals * Assessed data

Chart Visiomed Group

Dynamic Chart

Latest news about Visiomed Group

Visiomed: share price rises on 'record' 2023 results CF
Visiomed: 38% increase in annual sales CF
Visiomed: new CEO appointed CF
Visiomed: expands activities in Saudi Arabia CF
Visiomed Group Secures Location for Plan to Build Medical Center in Saudi Arabia MT
Visiomed Group SA's Equity Buyback announced on April 17, 2023, has expired. CI
Visiomed Group SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
CAC40: ends the day in green despite bond tensions CF
CAC40: rebound falters, rising interest rates cause concern CF
CAC40: back above 7,200 despite glowing interest rates CF
CAC40: starts the week in green, tops 7200 points CF
Visiomed: share price rises sharply on resumption of trading CF
CAC40: erases part of its losses before the close CF
CAC40: decline confirmed, stagnates above 7100 pts CF
CAC40: at 7100 points, the downturn deepens CF
More news

Analyst Recommendations on Visiomed Group

VISIOMED : EuroLand Corporate initiates Buy coverage CF
More recommendations

Press releases Visiomed Group

Visiomed Group Sa : Visiomed Group closes the year 2023 with a net profit of circa EUR1m AT
Visiomed : announces a new footfall record for its Smart Salem centers during the first quarter of 2024 PU
Visiomed Group Sa : Visiomed Group announces a new footfall record for its Smart Salem centers during the first quarter of 2024 AT
Visiomed Group Sa : FY 2023 results - a historic financial year for Visiomed Group AT
Visiomed Group Sa : Visiomed Group announces strong revenues growth in 2023 AT
More press releases

News in other languages on Visiomed Group

Visiomed : passe dans le vert en 2023
Le marché devient un peu timbré
En Direct des Marchés : Hermès, Schneider, Atos, Carrefour, Casino, Sanofi, STMicro, Meta...
Visiomed Group Sa : Visiomed Group boucle 2023 avec un résultat net positif de près de 1 MEUR
Visiomed Group Sa : Visiomed Group confirme son fort démarrage au premier trimestre 2024
More news

Managers and Directors - Visiomed Group

Managers TitleAgeSince
Clement Pacaud CEO
 Chief Executive Officer 34 22/01
Jérôme Fabreguettes-Leib IRC
 Investor Relations Contact - -
Thomas Picquette SEC
 Corporate Secretary - 01/22/01
Members of the board TitleAgeSince
Guillaume Bremond CHM
 Chairman - -
Sébastien Boucraut BRD
 Director/Board Member - -
Thomas Picquette SEC
 Corporate Secretary - 01/22/01
More insiders

Company Profile

Founded in 2007, Visiomed Group SA relies on a long experience to innovative healthcare technologies and services that will shape tomorrow's health and prevention. The Group now has focused its activities on the Middle East since 2021 with the acquisition of Smart Salem, the first digital medical analysis centre accredited by the Dubai Health Authority (DHA) in the United Arab Emirates, 100% owned by Visiomed Group SA. Visiomed Group SA is also stepping up its development in the region, with the creation of Smart Health, a joint venture which will drive the deployment of the group's innovative centers in Saudi Arabia.
Sector
Medical Equipment, Supplies & Distribution
More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ALVMG Stock
  4. 0D13 Stock